Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

FUJIFILM Pharmaceuticals U.S.A., Inc.FUJIFILM Pharmaceuticals U.S.A., Inc.
VS
Zydus GroupZydus Group
FUJIFILM Pharmaceuticals U.S.A., Inc.

FUJIFILM Pharmaceuticals U.S.A., Inc.

1 Broadway, Cambridge, 02142, US

Last Update: 24/01/2026

View Profile

About FUJIFILM Pharmaceuticals U.S.A., Inc. Our mission is to deliver innovative drugs to the broader population of patients worldwide at reasonable cost. FUJIFILM Pharmaceuticals U.S.A., Inc. started its operation in 2008 as FUJIFILM’s global center for new drug devel...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:8
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0
Zydus Group

Zydus Group

Zydus Corporate Park, Nr. Nirma University, Vasihnodevi circle, Mouje - Khoraj, Sarkhej - Gandhinagar Highway, Ahmedabad, Gujarat, IN, 382481

Last Update: 03/04/2026

View Profile
Between 750 and 799
http://www.zyduslife.com
780/1000Fair

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group ...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:20,544
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
FUJIFILM Pharmaceuticals U.S.A., Inc.

FUJIFILM Pharmaceuticals U.S.A., Inc.

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Zydus Group

Zydus Group

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for FUJIFILM Pharmaceuticals U.S.A., Inc. in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Zydus Group in 2026.

Incidents

Incident History - FUJIFILM Pharmaceuticals U.S.A., Inc. (X = Date, Y = Severity)

FUJIFILM Pharmaceuticals U.S.A., Inc. cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Zydus Group (X = Date, Y = Severity)

Zydus Group cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
FUJIFILM Pharmaceuticals U.S.A., Inc.

FUJIFILM Pharmaceuticals U.S.A., Inc.

Incidents
No explicit notable incidents reported.
Zydus Group

Zydus Group

Incidents
No explicit notable incidents reported.

FAQ

Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Zydus Group company, which one has the best AI Cybersecurity Score ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Zydus Group company, which one has experienced more cyber incidents in the past ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Zydus Group company, which one has experienced more cyber incidents this year ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Zydus Group company, which one has experienced at least one ransomware attack ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Zydus Group company, which one has experienced at least one data breach ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Zydus Group company, which one has experienced at least one targeted cyberattack ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Zydus Group company, which one has experienced at least one vulnerability ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Zydus Group company, which one holds the most compliance certifications ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Zydus Group company, which one holds the fewest compliance certifications ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Zydus Group company, which one has the most subsidiaries ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. company and Zydus Group company, which one has the largest number of employees ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. and Zydus Group, which company holds both SOC 2 Type 1 certifications ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. and Zydus Group, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - FUJIFILM Pharmaceuticals U.S.A., Inc. or Zydus Group ?
Which company is PCI DSS compliant - FUJIFILM Pharmaceuticals U.S.A., Inc. or Zydus Group ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. and Zydus Group, which company complies with HIPAA regulations for healthcare data ?
Between FUJIFILM Pharmaceuticals U.S.A., Inc. and Zydus Group, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-13512
SUMMARY

A vulnerability was identified in Databend up to 1.2.881 on HTTP. This affects the function ClientSessionManager::state_key of the file src/query/service/src/servers/http/v1/session/client_session_manager.rs of the component Tenant Handler. The manipulation leads to authorization bypass. It is possible to initiate the attack remotely. The exploit is publicly available and might be used. The pull request to fix this issue awaits acceptance.

PUBLISHED
Date2026-06-28
UPDATED
Date2026-06-28
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-13511
SUMMARY

A vulnerability was determined in VoltAgent up to 2.1.17. Affected by this issue is the function handleGetMemoryConversation of the file packages/server-core/src/handlers/memory.handlers.ts of the component Memory REST API. Executing a manipulation of the argument conversationId can lead to improper authorization. The attack may be performed from remote. This attack is characterized by high complexity. The exploitation is known to be difficult. The exploit has been publicly disclosed and may be utilized. The pull request to fix this issue awaits acceptance.

PUBLISHED
Date2026-06-28
UPDATED
Date2026-06-28
RISK INFORMATION (Score: 3.1)
CVSS2
Base Score: 2.1
Complexity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
CVSS3
Base Score: 3.1
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 1.3
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
1.6
CVE-2026-13510
SUMMARY

A vulnerability was found in SimStudioAI sim up to 0.6.92. Affected by this vulnerability is an unknown functionality in the library apps/sim/lib/core/security/deployment.ts of the component Password Protection Handler. Performing a manipulation results in use of weak hash. The attack is possible to be carried out remotely. The attack's complexity is rated as high. The exploitation appears to be difficult. The exploit has been made public and could be used. The pull request to fix this issue awaits acceptance.

PUBLISHED
Date2026-06-28
UPDATED
Date2026-06-28
RISK INFORMATION (Score: 3.7)
CVSS2
Base Score: 2.6
Complexity: HIGH
AV:N/AC:H/Au:N/C:P/I:N/A:N
CVSS3
Base Score: 3.7
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 2.9
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.2
CVE-2026-13509
SUMMARY

A vulnerability has been found in RAGapp up to 0.1.5. Affected is the function FileHandler.upload_file/FileHandler.remove_file of the file src/ragapp/backend/controllers/files.py of the component Knowledge File Handler. Such manipulation leads to path traversal. The attack can be executed remotely. The exploit has been disclosed to the public and may be used. The pull request to fix this issue awaits acceptance.

PUBLISHED
Date2026-06-28
UPDATED
Date2026-06-28
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-13508
SUMMARY

A flaw has been found in khoj-ai khoj up to 2.0.0-beta.28. This impacts an unknown function of the file src/khoj/routers/api_chat.py of the component Conversation Sharing Handler. This manipulation of the argument conversation.agent causes incorrect authorization. Remote exploitation of the attack is possible. The exploit has been published and may be used. The pull request to fix this issue awaits acceptance.

PUBLISHED
Date2026-06-28
UPDATED
Date2026-06-28
RISK INFORMATION (Score: 5.5)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 5.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.0
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.1